PhoreMost expands into new facility at Unity Campus, Cambridge, UK

PhoreMost Ltd., the UK-based biopharmaceutical company dedicated to ‘Drugging the Undruggable®’ disease targets, today announced it has relocated its headquarters to Unity Campus, a high-specification technology and innovation park, owned by leading regional property developers and investors, Howard Group, in south Cambridge.

Designed to support PhoreMost’s phenotypic screening requirements and expertise, the new bespoke 14,900 sq ft state-of-the-art facility is split equally between office and laboratory space, with an additional 4,000 sq ft of warehouse storage. The space, within The Works, Unity Campus’ latest combined office and R&D building, enables the Company to add in-house flow cytometry and imaging capabilities. Nearly doubling the size of its previous facilities, the relocation accommodates PhoreMost’s accelerated expansion and ongoing recruitment efforts within one location, including the recent appointment of Dr Christian Dillon as Chief Scientific Officer.

Based within the South Cambridge Science Cluster, PhoreMost’s relocation to Unity Campus places the Company in close proximity to numerous innovative life science and technology organisations, opening up opportunities for further collaborations with potential partners and researchers based at the Campus.

“Our move to Unity Campus follows a significant year for the Company, including a successful £33M Series B investment round in March 2021. As a team, remaining within the Cambridge biotech cluster is important, to help fuel new strategic collaborations, and support those already in progress. This move brings the whole team together in one site, where previously we were split across two buildings. With further space available at Unity Campus, we are well positioned to continue to advance and expand our drug discovery programmes across high value, but under-served, therapeutic areas.” 

Dr Chris Torrance, CEO, PhoreMost

Katherine Friend, Director - Investment & Asset Management, Howard Group, added: “The relocation of PhoreMost’s headquarters to Unity Campus exemplifies the specialist network of innovative, agile, science and technology organisations we are establishing here. We have thoroughly enjoyed working with the Phoremost team to tailor their new laboratory and office space within The Works and are excited to welcome them at such a pivotal time in the Company’s development. We look forward to continuing to work collaboratively with PhoreMost as it continues to grow.”

Having completed The Works in 2020, the second phase of Howard Group’s re-development of Unity Campus is now being brought forward. In response to market demand for agile, flexible science space, Phase 2 will consist of three buildings - totalling 95,000 sq ft - all specifically designed to provide high quality accommodation for life science occupiers. Each building will consist of ground, first and second floor office and laboratory accommodation, with landlord plant provision above. Subject to planning, it is anticipated that Phase 2 will be available from Q1 2023, with units from 10,000 sq ft now available for pre-let. Howard Group welcomes enquiries from potential occupiers wishing to engage at this early stage to enable bespoke requirements to be taken into account.

In addition to Phoremost, current life sciences occupiers at Unity Campus include Aqdot, IONTAS, Liminal Bioscience and Sareum.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    PhoreMost. (2023, February 17). PhoreMost expands into new facility at Unity Campus, Cambridge, UK. News-Medical. Retrieved on July 22, 2024 from

  • MLA

    PhoreMost. "PhoreMost expands into new facility at Unity Campus, Cambridge, UK". News-Medical. 22 July 2024. <>.

  • Chicago

    PhoreMost. "PhoreMost expands into new facility at Unity Campus, Cambridge, UK". News-Medical. (accessed July 22, 2024).

  • Harvard

    PhoreMost. 2023. PhoreMost expands into new facility at Unity Campus, Cambridge, UK. News-Medical, viewed 22 July 2024,


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
PhoreMost announces two key appointments to strengthen leadership team